Evidence map›Paper›PMID 30708357›Full record

ArticlePhysics in medicine and biology2019

Functional imaging of tumor vasculature using iodine and gadolinium-based nanoparticle contrast agents: a comparison of spectral micro-CT using energy integrating and photon counting detectors.

C T Badea, D P Clark, M Holbrook, M Srivastava, Y Mowery, K B Ghaghada

Open access · greenAbstract readComparative Study
In one paragraph

Article in Physics in medicine and biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 72 citations in OpenAlex.

  1. K-Edge imaging using a clinical dual-source photon-counting CT system.Journal of applied clinical medical physics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Edge-illumination spectral phase-contrast tomography.Physics in medicine and biology · 2024
    Article
  12. Contrast-enhanced photon-counting micro-CT of tumor xenograft models.bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

C T BadeaDepartment of Radiology, Center for In Vivo Microscopy, Duke University, Durham, NC 27710, United States of America.ORCID 0000-0002-1850-2522
D P ClarkDepartment of Radiology, Center for In Vivo Microscopy, Duke University, Durham, NC 27710, United States of America.
M HolbrookDepartment of Radiology, Center for In Vivo Microscopy, Duke University, Durham, NC 27710, United States of America.ORCID 0000-0002-5832-8725
M SrivastavaSingleton Department of Pediatric Radiology, Texas Children's Hospital, Houston, TX 77030, United States of America.
Y MoweryDepartment of Radiation Oncology, Duke University, Durham, NC 27710, United States of America.
K B GhaghadaSingleton Department of Pediatric Radiology, Texas Children's Hospital, Houston, TX 77030, United States of America.
Duke University · USTexas Children's Hospital · US

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI DONNA NIEDZWIECKI · 1985 to 2026
$174.8M
Training in Medical ImagingT32EB001040 · NIBIB · DUKE UNIVERSITY · PI NIGHTINGALE, KATHRYN RADABAUGH · 2003 to 2018
$4.4M
The Duke Preclinical Research Resources for Quantitative Imaging BiomarkersU24CA220245 · NCI · DUKE UNIVERSITY · PI BADEA, CRISTIAN T · 2017 to 2021
$2.8M
Development of a New Generation Micro-CT imaging for Functional and Molecular Imaging of CancerR01CA196667 · NCI · DUKE UNIVERSITY · PI BADEA, CRISTIAN T · 2015 to 2019
$2.3M
NCI NIH HHS P30 CA014236NCI NIH HHS R01 CA196667NCI NIH HHS U24 CA220245NIBIB NIH HHS T32 EB001040
6 · The paper itself

Abstract

Advances in computed tomography (CT) hardware have propelled the development of novel CT contrast agents. In particular, the spectral capabilities of x-ray CT can facilitate simultaneous imaging of multiple contrast agents. This approach is particularly useful for functional imaging of solid tumors by simultaneous visualization of multiple targets or architectural features that govern cancer development and progression. Nanoparticles are a promising platform for contrast agent development. While several novel imaging moieties based on high atomic number elements are being explored, iodine (I) and gadolinium (Gd) are particularly attractive because of their existing approval for clinical use. In this work, we investigate the in vivo discrimination of I and Gd nanoparticle contrast agents using both dual energy micro-CT with energy integrating detectors (DE-EID) and photon counting detector (PCD)-based spectral micro-CT. Simulations and phantom experiments were performed using varying concentrations of I and Gd to determine the imaging performance with optimized acquisition parameters. Quantitative spectral micro-CT imaging using liposomal-iodine (Lip-I) and liposomal-Gd (Lip-Gd) nanoparticle contrast agents was performed in sarcoma bearing mice for anatomical and functional imaging of tumor vasculature. Iterative reconstruction provided high sensitivity to detect and discriminate relatively low I and Gd concentrations. According to the Rose criterion applied to the experimental results, the detectability limits for I and Gd were approximately 2.5 mg ml

Indexed as

Contrast MediaPhantoms, ImagingAnimalsGadoliniumHumansIodineMagnetic Resonance ImagingMiceMice, Inbred C57BLNanoparticlesNeovascularization, PathologicPhotonsSarcomaTomography Scanners, X-Ray ComputedX-Ray MicrotomographyContrast MediaGadoliniumIodine

Identifiers

PMID30708357
PMCPMC6607440
OpenAlexW2914136035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.